CME Group (CME) Chief Transformation Officer Ken Vroman Receives Award

What Happened

• Ken Vroman, Chief Transformation Officer of CME Group, received a grant of 2,592 restricted shares on 2026-09-15 valued at $275.09 each (total ≈ $713,033).
• To satisfy tax withholding on the vesting of restricted stock, Vroman surrendered a total of 1,211 shares across transactions on 2026-09-15 and 2026-09-16 for aggregate proceeds of ≈ $332,325. These were not open-market sales but shares surrendered to the company to cover taxes.

Key Details

• Transactions:
  • 2026-09-15 — Award (A): 2,592 shares @ $275.09 = $713,033 (grant of restricted stock).
  • 2026-09-15 — Tax withholding (F): 320 shares @ $275.09 = $88,029 (surrendered).
  • 2026-09-15 — Tax withholding (F): 309 shares @ $275.09 = $85,003 (surrendered).
  • 2026-09-15 — Tax withholding (F): 274 shares @ $275.09 = $75,375 (surrendered).
  • 2026-09-16 — Tax withholding (F): 308 shares @ $272.46 = $83,918 (surrendered).
• Shares surrendered total: 1,211 shares; total value surrendered ≈ $332,325.
• Shares owned after the transactions: not specified in the provided filing data.
• Filing: Report filed 2026-09-17 for transactions occurring 2026-09-15–09-16 — appears to be timely (Form 4 due within two business days).
• Footnotes:
  • F1: The grant is restricted stock under CME Group’s Omnibus Stock Plan, vesting in four equal annual installments subject to continued service.
  • F2: The disposals represent shares surrendered to the issuer to satisfy tax withholding obligations upon vesting.

Context

• This was an equity award (restricted stock) granted to an executive, with some shares surrendered to cover taxes — a routine administrative action rather than an open-market sale or buy. Such tax-withholding dispositions (code F) do not necessarily signal a change in insider sentiment because they often reflect standard vesting and tax requirements.